Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe miRNA Tools and Services Market, by Technology
1.4.2 Europe miRNA Tools and Services Market, by End User
1.4.3 Europe miRNA Tools and Services Market, by Product & Services
1.4.4 Europe miRNA Tools and Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe miRNA Tools and Services Market by Technology
3.1 Europe qRT-PCR Market by Country
3.2 Europe Extraction Tools Market by Country
3.3 Europe NGS Market by Country
3.4 Europe Microarray Market by Country
3.5 Europe Functional Analysis Tools Market by Country
3.6 Europe Others Market by Country
Chapter 4. Europe miRNA Tools and Services Market by End User
4.1 Europe Research & Academic Institutes Market by Country
4.2 Europe IVD, Pharma & Biotech Companies Market by Country
4.3 Europe CROs Market by Country
Chapter 5. Europe miRNA Tools and Services Market by Product & Services
5.1 Europe Research Tools Market by Country
5.2 Europe Services Market by Country
Chapter 6. Europe miRNA Tools and Services Market by Country
6.1 Germany miRNA Tools and Services Market
6.1.1 Germany miRNA Tools and Services Market by Technology
6.1.2 Germany miRNA Tools and Services Market by End User
6.1.3 Germany miRNA Tools and Services Market by Product & Services
6.2 UK miRNA Tools and Services Market
6.2.1 UK miRNA Tools and Services Market by Technology
6.2.2 UK miRNA Tools and Services Market by End User
6.2.3 UK miRNA Tools and Services Market by Product & Services
6.3 France miRNA Tools and Services Market
6.3.1 France miRNA Tools and Services Market by Technology
6.3.2 France miRNA Tools and Services Market by End User
6.3.3 France miRNA Tools and Services Market by Product & Services
6.4 Russia miRNA Tools and Services Market
6.4.1 Russia miRNA Tools and Services Market by Technology
6.4.2 Russia miRNA Tools and Services Market by End User
6.4.3 Russia miRNA Tools and Services Market by Product & Services
6.5 Spain miRNA Tools and Services Market
6.5.1 Spain miRNA Tools and Services Market by Technology
6.5.2 Spain miRNA Tools and Services Market by End User
6.5.3 Spain miRNA Tools and Services Market by Product & Services
6.6 Italy miRNA Tools and Services Market
6.6.1 Italy miRNA Tools and Services Market by Technology
6.6.2 Italy miRNA Tools and Services Market by End User
6.6.3 Italy miRNA Tools and Services Market by Product & Services
6.7 Rest of Europe miRNA Tools and Services Market
6.7.1 Rest of Europe miRNA Tools and Services Market by Technology
6.7.2 Rest of Europe miRNA Tools and Services Market by End User
6.7.3 Rest of Europe miRNA Tools and Services Market by Product & Services
Chapter 7. Company Profiles
7.1 General Electric (GE) Co.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Agilent Technologies, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Thermo Fisher Scientific, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Bio-Rad laboratories, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Qiagen N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.5.5.3 Acquisition and Mergers:
7.6 Illumina, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.7 New England BioLabs, Inc.
7.7.1 Company Overview
7.8 Promega Corporation
7.8.1 Company Overview
7.9 GeneCopoeia, Inc.
7.9.1 Company Overview
7.10. Norgen Biotek Corp.
7.10.1 Company Overview
Unique Offerings 
